{"id":14828,"date":"2021-05-07T17:29:01","date_gmt":"2021-05-07T17:29:01","guid":{"rendered":"https:\/\/valutico.com\/weekly-valuations-pfizer\/"},"modified":"2023-11-24T15:57:58","modified_gmt":"2023-11-24T15:57:58","slug":"weekly-valuations-pfizer","status":"publish","type":"post","link":"https:\/\/valutico.com\/weekly-valuations-pfizer\/","title":{"rendered":"Weekly Valuations: Pfizer"},"content":{"rendered":"

Pharmaceutical giant Pfizer beat earnings expectations this week, the company lifted its guidance and also announced plans to donate Covid-19 vaccines to Olympic athletes for the upcoming summer games.<\/span><\/p>\n

Turned into a mainstream discussion topic by the pandemic, the pharmaceutical giant capitalized on its success in creating a vaccine to reap huge rewards, for the year 2021, Pfizer estimates it could generate as much as $26 billion in revenue, an increase from earlier estimates of \u201cjust\u201d $15 billion.<\/span><\/p>\n

That said, many analysts remain cautious about the company\u2019s outlook beyond the pandemic, as concerns over its long term pipeline remain.<\/span><\/p>\n

But what is Pfizer really worth:<\/span><\/p>\n

With a market cap of $223Bn the company is the 3rd largest in its market, behind JnJ and Roche, but is it fairly valued?<\/span><\/p>\n

Our income based models, both DCF and DDM seem to suggest it could be as much as $100Bn undervalued, as they both yield values north of $300Bn (assuming, per analysts consensus estimates that 2021 revenue represents nearly 70% growth over 2020, and that 2022 would see a large retraction post-vaccine).<\/span><\/p>\n

But our market based methods seem more in line with the company\u2019s current market cap, closer to $250Bn<\/span><\/p>\n

What is your outlook on the pharma behemoth?<\/span><\/p>\n

\"Pfizer<\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

Link to the valuation: <\/span>https:\/\/valutico.com\/companies\/pfizer-inc-2560cf49-4d10-4316-afa3-23d606bcbc4c\/evaluations\/I84M2X6WrO6JcS7CdW9cFpJzPbi6IuDv6lnHIpPCWZGdRWXpZ6JUmuXQSmn4XQWXoC6UgUmGyGRc5vRT28FRRA\/share<\/span><\/a><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Pharmaceutical giant Pfizer beat earnings expectations this week, the company […]<\/p>\n","protected":false},"author":7,"featured_media":21480,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"inline_featured_image":false,"footnotes":""},"categories":[35],"tags":[56,61,39],"yoast_head":"\nWeekly Valuations: Pfizer - Valutico | April 2021 valuation<\/title>\n<meta name=\"description\" content=\"Valutico performs a weekly valuation exercise to assess whether famous companies are undervalued or overvalued. Today's target is Pfizer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/valutico.com\/weekly-valuations-pfizer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Weekly Valuations: Pfizer - Valutico | April 2021 valuation\" \/>\n<meta property=\"og:description\" content=\"Valutico performs a weekly valuation exercise to assess whether famous companies are undervalued or overvalued. Today's target is Pfizer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/valutico.com\/weekly-valuations-pfizer\/\" \/>\n<meta property=\"og:site_name\" content=\"Valutico\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-07T17:29:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-24T15:57:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/valutico.com\/wp-content\/uploads\/2021\/05\/Pfizer-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1696\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Chris Botha\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Chris Botha\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/valutico.com\/weekly-valuations-pfizer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/valutico.com\/weekly-valuations-pfizer\/\"},\"author\":{\"name\":\"Chris Botha\",\"@id\":\"https:\/\/valutico.com\/#\/schema\/person\/d4a2dd3736ec198b4cf14a204db27af3\"},\"headline\":\"Weekly Valuations: Pfizer\",\"datePublished\":\"2021-05-07T17:29:01+00:00\",\"dateModified\":\"2023-11-24T15:57:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/valutico.com\/weekly-valuations-pfizer\/\"},\"wordCount\":250,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/valutico.com\/#organization\"},\"keywords\":[\"Valuations\",\"valutico\",\"WeeklyValuations\"],\"articleSection\":[\"Valuations\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/valutico.com\/weekly-valuations-pfizer\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/valutico.com\/weekly-valuations-pfizer\/\",\"url\":\"https:\/\/valutico.com\/weekly-valuations-pfizer\/\",\"name\":\"Weekly Valuations: Pfizer - Valutico | April 2021 valuation\",\"isPartOf\":{\"@id\":\"https:\/\/valutico.com\/#website\"},\"datePublished\":\"2021-05-07T17:29:01+00:00\",\"dateModified\":\"2023-11-24T15:57:58+00:00\",\"description\":\"Valutico performs a weekly valuation exercise to assess whether famous companies are undervalued or overvalued. Today's target is Pfizer.\",\"breadcrumb\":{\"@id\":\"https:\/\/valutico.com\/weekly-valuations-pfizer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/valutico.com\/weekly-valuations-pfizer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/valutico.com\/weekly-valuations-pfizer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/valutico.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Weekly Valuations: Pfizer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/valutico.com\/#website\",\"url\":\"https:\/\/valutico.com\/\",\"name\":\"Valutico\",\"description\":\"Measure Value\",\"publisher\":{\"@id\":\"https:\/\/valutico.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/valutico.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/valutico.com\/#organization\",\"name\":\"Valutico\",\"url\":\"https:\/\/valutico.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/valutico.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/valutico.com\/wp-content\/uploads\/2021\/03\/V-in-Blue-Green.png\",\"contentUrl\":\"https:\/\/valutico.com\/wp-content\/uploads\/2021\/03\/V-in-Blue-Green.png\",\"width\":615,\"height\":875,\"caption\":\"Valutico\"},\"image\":{\"@id\":\"https:\/\/valutico.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/valutico.com\/#\/schema\/person\/d4a2dd3736ec198b4cf14a204db27af3\",\"name\":\"Chris Botha\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/valutico.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/valutico.com\/wp-content\/uploads\/2023\/03\/Chris-Botha-96x96.jpeg\",\"contentUrl\":\"https:\/\/valutico.com\/wp-content\/uploads\/2023\/03\/Chris-Botha-96x96.jpeg\",\"caption\":\"Chris Botha\"},\"description\":\"Chris Botha has over 12 years experience in corporate finance and M&A. Prior to working in corporate finance Chris studied at the University of Johannesburg where he gained an honours degree in investment management. Chris is also a CFA Charterholder.\",\"url\":\"https:\/\/valutico.com\/author\/chris-botha\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Weekly Valuations: Pfizer - Valutico | April 2021 valuation","description":"Valutico performs a weekly valuation exercise to assess whether famous companies are undervalued or overvalued. Today's target is Pfizer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/valutico.com\/weekly-valuations-pfizer\/","og_locale":"en_US","og_type":"article","og_title":"Weekly Valuations: Pfizer - Valutico | April 2021 valuation","og_description":"Valutico performs a weekly valuation exercise to assess whether famous companies are undervalued or overvalued. Today's target is Pfizer.","og_url":"https:\/\/valutico.com\/weekly-valuations-pfizer\/","og_site_name":"Valutico","article_published_time":"2021-05-07T17:29:01+00:00","article_modified_time":"2023-11-24T15:57:58+00:00","og_image":[{"width":2560,"height":1696,"url":"https:\/\/valutico.com\/wp-content\/uploads\/2021\/05\/Pfizer-scaled.jpg","type":"image\/jpeg"}],"author":"Chris Botha","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Chris Botha","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/valutico.com\/weekly-valuations-pfizer\/#article","isPartOf":{"@id":"https:\/\/valutico.com\/weekly-valuations-pfizer\/"},"author":{"name":"Chris Botha","@id":"https:\/\/valutico.com\/#\/schema\/person\/d4a2dd3736ec198b4cf14a204db27af3"},"headline":"Weekly Valuations: Pfizer","datePublished":"2021-05-07T17:29:01+00:00","dateModified":"2023-11-24T15:57:58+00:00","mainEntityOfPage":{"@id":"https:\/\/valutico.com\/weekly-valuations-pfizer\/"},"wordCount":250,"commentCount":0,"publisher":{"@id":"https:\/\/valutico.com\/#organization"},"keywords":["Valuations","valutico","WeeklyValuations"],"articleSection":["Valuations"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/valutico.com\/weekly-valuations-pfizer\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/valutico.com\/weekly-valuations-pfizer\/","url":"https:\/\/valutico.com\/weekly-valuations-pfizer\/","name":"Weekly Valuations: Pfizer - Valutico | April 2021 valuation","isPartOf":{"@id":"https:\/\/valutico.com\/#website"},"datePublished":"2021-05-07T17:29:01+00:00","dateModified":"2023-11-24T15:57:58+00:00","description":"Valutico performs a weekly valuation exercise to assess whether famous companies are undervalued or overvalued. Today's target is Pfizer.","breadcrumb":{"@id":"https:\/\/valutico.com\/weekly-valuations-pfizer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/valutico.com\/weekly-valuations-pfizer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/valutico.com\/weekly-valuations-pfizer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/valutico.com\/"},{"@type":"ListItem","position":2,"name":"Weekly Valuations: Pfizer"}]},{"@type":"WebSite","@id":"https:\/\/valutico.com\/#website","url":"https:\/\/valutico.com\/","name":"Valutico","description":"Measure Value","publisher":{"@id":"https:\/\/valutico.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/valutico.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/valutico.com\/#organization","name":"Valutico","url":"https:\/\/valutico.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/valutico.com\/#\/schema\/logo\/image\/","url":"https:\/\/valutico.com\/wp-content\/uploads\/2021\/03\/V-in-Blue-Green.png","contentUrl":"https:\/\/valutico.com\/wp-content\/uploads\/2021\/03\/V-in-Blue-Green.png","width":615,"height":875,"caption":"Valutico"},"image":{"@id":"https:\/\/valutico.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/valutico.com\/#\/schema\/person\/d4a2dd3736ec198b4cf14a204db27af3","name":"Chris Botha","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/valutico.com\/#\/schema\/person\/image\/","url":"https:\/\/valutico.com\/wp-content\/uploads\/2023\/03\/Chris-Botha-96x96.jpeg","contentUrl":"https:\/\/valutico.com\/wp-content\/uploads\/2023\/03\/Chris-Botha-96x96.jpeg","caption":"Chris Botha"},"description":"Chris Botha has over 12 years experience in corporate finance and M&A. Prior to working in corporate finance Chris studied at the University of Johannesburg where he gained an honours degree in investment management. Chris is also a CFA Charterholder.","url":"https:\/\/valutico.com\/author\/chris-botha\/"}]}},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Valutico","distributor_original_site_url":"https:\/\/valutico.com","push-errors":false,"_links":{"self":[{"href":"https:\/\/valutico.com\/wp-json\/wp\/v2\/posts\/14828"}],"collection":[{"href":"https:\/\/valutico.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/valutico.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/valutico.com\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/valutico.com\/wp-json\/wp\/v2\/comments?post=14828"}],"version-history":[{"count":1,"href":"https:\/\/valutico.com\/wp-json\/wp\/v2\/posts\/14828\/revisions"}],"predecessor-version":[{"id":16871,"href":"https:\/\/valutico.com\/wp-json\/wp\/v2\/posts\/14828\/revisions\/16871"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/valutico.com\/wp-json\/wp\/v2\/media\/21480"}],"wp:attachment":[{"href":"https:\/\/valutico.com\/wp-json\/wp\/v2\/media?parent=14828"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/valutico.com\/wp-json\/wp\/v2\/categories?post=14828"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/valutico.com\/wp-json\/wp\/v2\/tags?post=14828"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}